Isoproterenol inhibits bacterial lipopolysaccharide-stimulated release of tumor necrosis factor-α from human heart tissue

American Surgeon

Volumn 66, Issue 10, 2000, Pages 947-951

  Smart K R , Jr ^a   Warejcka, D J ^a   Castresana, M R ^a   Dalton, M L ^a   Webb, J G ^a   Newman, W H ^a   Galandiuk, S ^a   Van de Water, J M ^a   Schert, F W ^a  

^a MEDICAL CENTER OF CENTRAL GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYTOKINE; ISOPRENALINE; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; ANGINA PECTORIS; ARTICLE; CARDIOPULMONARY BYPASS; CONGESTIVE HEART FAILURE; CYTOKINE RELEASE; CYTOTOXICITY; DRUG INHIBITION; HEART INFARCTION; HEART MUSCLE CELL; HEART SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; MACROPHAGE; RELIABILITY; SYMPATHETIC FUNCTION;

ANIMAL; CELL LINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; HEART ATRIUM; HEART FAILURE, CONGESTIVE; HUMAN; LIPOPOLYSACCHARIDES; MICE; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA; SYMPATHETIC NERVOUS SYSTEM; TUMOR NECROSIS FACTOR;

EID: 0033774281     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
2. Tumor necrosis factor α in severe congestive heart failure
3. Enhanced secretion of tumor necrosis factor in patients with myocardial infarction
4. Assessment of myocardial injury by serum tumor necrosis factor α measurements in acute myocardial infarction
5. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass
6. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization
7. Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure
8. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy
9. Human myocardial tissue TNF-α expression following acute global ischemia
10. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration
11. Tumor necrosis factor-α is released from the isolated heart undergoing ischemia and reperfusion
12. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-α production: Potential ultimate effector mechanism of preconditioning
13. Tumor necrosis factor in the heart
14. Pharmacologic reduction of tumor necrosis factor activity of pulmonary macrophages
15. Inhibition of release of tumor necrosis factor-α from human vascular tissue and smooth muscle cells by glucocorticoids
16. 2 regulates macrophage-derived tumor necrosis factor gene expression
17. Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-α
18. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor
19. Nitric oxide regulates endotoxin-induced TNF-α production in human neutrophils
20. Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP
21. Isoproterenol inhibits IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages
22. 2-adrenoreceptor activation
23. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor
24. Radioimmunoassay of cyclic AMP and cyclic GMP
25. 2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: Mechanisms of action
26. 2-adrenoceptor in rat astrocytes
27. Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes
28. Elevated cyclic AMP inhibits NF-kB-mediated transcription in human monocytic cells and endothelial cells
29. A depressed response of left ventricular contractile force to isoproterenol and norepinephrine in dogs with congestive heart failure
30. Study of normal and failing isolated human heart: Decreased response of failing heart to isoproterenol
31. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure